Although Sarepta Therapeutics…
Although Sarepta Therapeutics managed to defuse a brief stalemate with [...]
A soon-to-be-released documentary…
A soon-to-be-released documentary aims to change the conversation around hemophilia, [...]
A direct-to-consumer program for…
A direct-to-consumer program for its drugs could bring down higher [...]
U.S. Quietly Drafts Plan to End Program That Saved Millions From AIDS
PEPFAR, the campaign to end H.I.V. globally, would morph into [...]
A Pill for Sleep Apnea Could Be on the Horizon
Experts say that if the new drug gets approved, it [...]
AstraZeneca Joins Pharma Investment Push in U.S. Amid Tariff Threat
The U.K.-based drugmaker plans to invest $50 billion in the [...]
First Pill for Postpartum Depression Shows Varied Real-World Results
Some women’s symptoms improved quickly after taking the pill, but [...]
F.D.A. Panel Debates ‘Black Box’ Warning for Antidepressants in Pregnancy
An agency-sponsored forum included critics of psychiatry who believe the [...]
Sarepta Refuses FDA Request to Stop Shipping Muscular Dystrophy Drug Elevidys
The regulator had asked Sarepta Therapeutics to halt all shipments [...]
Heath Insurers Are Denying More Drug Claims, Data Shows
Offering a rare glimpse inside the hidden world of rejected [...]